
2.16 Delayed Data As of Mar 31 | ![]() Today’s Change | 0.53 Today|||52-Week Range 3.85 | -41.62% Year-to-Date |
Why Shares of ProQR Therapeutics Dropped on Wednesday Mar 29 / MotleyFool.com - Paid Partner Content |
Previous close | 1.99 |
Today’s open | 1.95 |
Day’s range | 1.92 - 2.22 |
Volume | 64,026 |
Average volume (3 months) | 2,411,034 |
Market cap | $170.5M |
Earnings growth (last year) | +15.83% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +165.11% |
P/E ratio | NM |
Price/Sales | 62.48 |
Price/Book | 2.34 |
Today’s change | Today’s % change | |
---|---|---|
CTXRCitius Pharmaceutica... | -0.01 | -0.85% |
FULCFulcrum Therapeutics... | +0.01 | +0.36% |
AADIAadi Bioscience Inc | +0.12 | +1.69% |
DMTRF3-D Matrix Ltd | 0.00 | 0.00% |
Next reporting date | May 10, 2023 |
EPS forecast (this quarter) | -$0.13 |
Annual revenue (last year) | $4.2M |
Annual profit (last year) | -$68.4M |
Net profit margin | -1,612.86% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leiden, Zuid-holland |